New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

1

Avian Flu Spike in Humans Creates Concern

Scientists are scrambling to find the cause for the sudden spike in human cases of avian influenza A (H5N6) in China to 21 during year-to-date 2021, from only five in 2020, reports say.

2

Lilly, Merck and Bayer Back a New Composer for Autoimmune Therapies

Seattle-based Mozart Therapeutics closed on a $55 million Series A financing round, led by seed financier ARCH Venture Partners along with Sofinnova Partners. Additional investors were Eli Lilly and Company, MRL Ventures Fund, an early-stage fund run by Merck & Co., Leaps by Bayer, Altitude Life Science Ventures, and Alexandria Venture Investments.

7

AstraZeneca Announces Potential Breakthrough in Advanced Biliary Tract Cancer

AstraZeneca shared positive results from the company’s TOPAZ-1 Phase III trial on Imfinzi (durvalumab) in increasing the chances for survival in advanced biliary tract cancer patients when combined with standard-of-care chemotherapy regimens.

9

Regeneron, Sanofi on a Roll as Dupixent Scores Second Consecutive Phase III Win

Dupixent (dupilumab) scored the blockbuster medicine’s second study win in a week after Regeneron Pharmaceuticals and Sanofi revealed positive results from the second Phase III trial for the treatment of eosinophilic esophagitis (EoE).